<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01797783</url>
  </required_header>
  <id_info>
    <org_study_id>C-12-054</org_study_id>
    <nct_id>NCT01797783</nct_id>
  </id_info>
  <brief_title>Clinical Evaluation of the Safety and Efficacy of a New Multifocal Contact Lens</brief_title>
  <official_title>Clinical Evaluation of the Safety and Efficacy of a New Multifocal Contact Lens</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alcon Research</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alcon Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study was to demonstrate substantial equivalence of the new DAILIES®
      AquaComfort Plus® Multifocal (DACP MF) contact lens to the commercially available Focus®
      DAILIES® Progressives (FDP) contact lens.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Actual">April 2013</completion_date>
  <primary_completion_date type="Actual">April 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Subjective Overall Vision</measure>
    <time_frame>Up to Day 30</time_frame>
    <description>The participant was instructed to, &quot;Please rate the aggregate of distance, intermediate, and near vision quality. Fill in the circle below the number that indicates your selection. Rate eyes together, marking only 1 circle for both eyes. Higher numbers mean better vision.&quot; The response was recorded on a continuous scale from 1-10 (1=poor, 10=excellent).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Binocular Snellen Visual Acuity (VA) at Distance With Study Lenses</measure>
    <time_frame>Up to Day 30</time_frame>
    <description>Visual Acuity was tested while reading a chart at 20-foot equivalent distance from the participant with both eyes together. The Snellen fraction compares the participant's result to the result expected from the 'normal' visual system. The numerator represents the distance between the participant and the chart, and the denominator represents the distance at which a person with 'normal' vision would be able to discern the same letter size. 20/20 is considered to be 'normal' vision, whereas visual acuity of 20/40 means the participant is able to read a certain size letter 20 feet away that a person with 'normal' vision would be able to read from 40 feet away. A larger denominator, therefore, indicates a lower visual acuity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Binocular Snellen Visual Acuity (VA) at Near (40cm) With Study Lenses</measure>
    <time_frame>Up to Day 30</time_frame>
    <description>Visual Acuity was tested while reading charts at a distance of 40 cm from the participant with both eyes together. The Snellen fraction 20/20 represents 'normal' near vision. A larger denominator indicates a lower visual acuity.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">83</enrollment>
  <condition>Myopia</condition>
  <condition>Ametropia</condition>
  <condition>Presbyopia</condition>
  <condition>Refractive Error</condition>
  <arm_group>
    <arm_group_label>DAILIES® AquaComfort Plus® Multifocal</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Nelfilcon A multifocal contact lens with comfort additive worn for 30 days on a daily wear, daily disposable basis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Focus® DAILIES® Progressives</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Nelfilcon A multifocal contact lens worn for 30 days on a daily wear, daily disposable basis</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nelfilcon A multifocal contact lens with comfort additive</intervention_name>
    <arm_group_label>DAILIES® AquaComfort Plus® Multifocal</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nelfilcon A multifocal contact lens</intervention_name>
    <arm_group_label>Focus® DAILIES® Progressives</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Sign Informed Consent Document.

          -  Presbyopic and require a spectacle add of up to and including 3.00 diopters (D).

          -  Currently wear soft contact lenses.

          -  Willing and able to wear multifocal contact lenses in both eyes within the available
             range of powers for this trial and comply with the wearing and replacement schedule.

          -  Manifest cylinder less than or equal to 1.00 D.

          -  Able to achieve best corrected visual acuity (BCVA) of 20/25 or better (Snellen) in
             each eye at distance (as determined by manifest refraction).

          -  Able to achieve distance visual acuity of 20/40 (Snellen) or better in each eye with
             study lenses and deem subjective vision as satisfactory at time of dispense.

          -  Other protocol-defined inclusion criteria may apply.

        Exclusion Criteria:

          -  Any anterior segment infection, inflammation, disease, or abnormality that
             contraindicates contact lens wear within 6 months prior to enrollment.

          -  Any use of systemic or ocular medications for which contact lens wear could be
             contraindicated.

          -  History of corneal or refractive surgery.

          -  Biomicroscopy findings greater than Grade 2 at baseline.

          -  A pathologically dry eye that precludes contact lens wear.

          -  Monocular (only one eye with functional vision).

          -  Wear habitual contact lenses on an extended wear schedule (any number of nights of
             overnight wear on a regular basis).

          -  History of intolerance or hypersensitivity to any component of the investigational
             products.

          -  Concurrent participation in a contact lens or contact lens care product clinical trial
             or within the previous 30 days.

          -  Eye injury or ocular or intra-ocular surgery within 6 months prior to enrollment.

          -  Other protocol-defined exclusion criteria may apply.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Justin Webb, O.D.</last_name>
    <role>Study Director</role>
    <affiliation>Alcon Research</affiliation>
  </overall_official>
  <removed_countries>
    <country>United States</country>
  </removed_countries>
  <verification_date>April 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 21, 2013</study_first_submitted>
  <study_first_submitted_qc>February 21, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 25, 2013</study_first_posted>
  <results_first_submitted>April 25, 2014</results_first_submitted>
  <results_first_submitted_qc>April 25, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">May 23, 2014</results_first_posted>
  <last_update_submitted>April 25, 2014</last_update_submitted>
  <last_update_submitted_qc>April 25, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 23, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Myopia</keyword>
  <keyword>Presbyopia</keyword>
  <keyword>Refractive error</keyword>
  <keyword>Contact lenses</keyword>
  <keyword>Multifocal</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myopia</mesh_term>
    <mesh_term>Presbyopia</mesh_term>
    <mesh_term>Refractive Errors</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants were recruited from 9 study centers located in the United States.</recruitment_details>
      <pre_assignment_details>Of the 83 consented participants, 2 were exited as screen failures prior to randomization, and 2 were exited after randomization but prior to product dispense. This reporting group includes all randomized participants who were dispensed study product (79).</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>DAILIES® AquaComfort Plus® Multifocal</title>
          <description>Nelfilcon A multifocal contact lens with comfort additive worn for 30 days on a daily wear, daily disposable basis</description>
        </group>
        <group group_id="P2">
          <title>Focus® DAILIES® Progressives</title>
          <description>Nelfilcon A multifocal contact lens worn for 30 days on a daily wear, daily disposable basis</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="52"/>
                <participants group_id="P2" count="27"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="50"/>
                <participants group_id="P2" count="26"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>This analysis population includes all randomized participants who were dispensed study product (79).</population>
      <group_list>
        <group group_id="B1">
          <title>DAILIES® AquaComfort Plus® Multifocal</title>
          <description>Nelfilcon A multifocal contact lens with comfort additive worn for 30 days on a daily wear, daily disposable basis</description>
        </group>
        <group group_id="B2">
          <title>Focus® DAILIES® Progressives</title>
          <description>Nelfilcon A multifocal contact lens worn for 30 days on a daily wear, daily disposable basis</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="52"/>
            <count group_id="B2" value="27"/>
            <count group_id="B3" value="79"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="49.9" spread="5.19"/>
                    <measurement group_id="B2" value="49.7" spread="5.21"/>
                    <measurement group_id="B3" value="49.8" spread="5.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="34"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Subjective Overall Vision</title>
        <description>The participant was instructed to, &quot;Please rate the aggregate of distance, intermediate, and near vision quality. Fill in the circle below the number that indicates your selection. Rate eyes together, marking only 1 circle for both eyes. Higher numbers mean better vision.&quot; The response was recorded on a continuous scale from 1-10 (1=poor, 10=excellent).</description>
        <time_frame>Up to Day 30</time_frame>
        <population>This analysis population includes all randomized and dispensed participants who completed the study. No imputation was used for missing values. Here, &quot;n&quot; is the number of participants with non-missing values at the specific time point for each arm.
group,</population>
        <group_list>
          <group group_id="O1">
            <title>DAILIES® AquaComfort Plus® Multifocal</title>
            <description>Nelfilcon A multifocal contact lens with comfort additive worn for 30 days on a daily wear, daily disposable basis</description>
          </group>
          <group group_id="O2">
            <title>Focus® DAILIES® Progressives</title>
            <description>Nelfilcon A multifocal contact lens worn for 30 days on a daily wear, daily disposable basis</description>
          </group>
        </group_list>
        <measure>
          <title>Subjective Overall Vision</title>
          <description>The participant was instructed to, &quot;Please rate the aggregate of distance, intermediate, and near vision quality. Fill in the circle below the number that indicates your selection. Rate eyes together, marking only 1 circle for both eyes. Higher numbers mean better vision.&quot; The response was recorded on a continuous scale from 1-10 (1=poor, 10=excellent).</description>
          <population>This analysis population includes all randomized and dispensed participants who completed the study. No imputation was used for missing values. Here, &quot;n&quot; is the number of participants with non-missing values at the specific time point for each arm.
group,</population>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Dispense (Day 0) (n=49,26)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.7" spread="1.1"/>
                    <measurement group_id="O2" value="8.4" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 3 (n=49,26)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.4" spread="1.3"/>
                    <measurement group_id="O2" value="7.5" spread="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14 (n=50,26)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.6" spread="1.2"/>
                    <measurement group_id="O2" value="7.7" spread="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 30 (n=50,26)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.5" spread="1.1"/>
                    <measurement group_id="O2" value="7.6" spread="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Binocular Snellen Visual Acuity (VA) at Distance With Study Lenses</title>
        <description>Visual Acuity was tested while reading a chart at 20-foot equivalent distance from the participant with both eyes together. The Snellen fraction compares the participant's result to the result expected from the ’normal’ visual system. The numerator represents the distance between the participant and the chart, and the denominator represents the distance at which a person with 'normal' vision would be able to discern the same letter size. 20/20 is considered to be 'normal' vision, whereas visual acuity of 20/40 means the participant is able to read a certain size letter 20 feet away that a person with 'normal' vision would be able to read from 40 feet away. A larger denominator, therefore, indicates a lower visual acuity.</description>
        <time_frame>Up to Day 30</time_frame>
        <population>This analysis population includes all randomized and dispensed participants who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>DACP MF @ Dispense</title>
            <description>Nelfilcon A multifocal contact lens with comfort additive worn for 30 days on a daily wear, daily disposable basis</description>
          </group>
          <group group_id="O2">
            <title>DACP MF @ Day 3</title>
            <description>Nelfilcon A multifocal contact lens with comfort additive worn for 30 days on a daily wear, daily disposable basis</description>
          </group>
          <group group_id="O3">
            <title>DACP MF @ Day 14</title>
            <description>Nelfilcon A multifocal contact lens with comfort additive worn for 30 days on a daily wear, daily disposable basis</description>
          </group>
          <group group_id="O4">
            <title>DACP MF @ Day 30</title>
            <description>Nelfilcon A multifocal contact lens with comfort additive worn for 30 days on a daily wear, daily disposable basis</description>
          </group>
          <group group_id="O5">
            <title>FDP @ Dispense</title>
            <description>Nelfilcon A multifocal contact lens worn for 30 days on a daily wear, daily disposable basis</description>
          </group>
          <group group_id="O6">
            <title>FDP @ Day 3</title>
            <description>Nelfilcon A multifocal contact lens worn for 30 days on a daily wear, daily disposable basis</description>
          </group>
          <group group_id="O7">
            <title>FDP @ Day 14</title>
            <description>Nelfilcon A multifocal contact lens worn for 30 days on a daily wear, daily disposable basis</description>
          </group>
          <group group_id="O8">
            <title>FDP @ Day 30</title>
            <description>Nelfilcon A multifocal contact lens worn for 30 days on a daily wear, daily disposable basis</description>
          </group>
        </group_list>
        <measure>
          <title>Binocular Snellen Visual Acuity (VA) at Distance With Study Lenses</title>
          <description>Visual Acuity was tested while reading a chart at 20-foot equivalent distance from the participant with both eyes together. The Snellen fraction compares the participant's result to the result expected from the ’normal’ visual system. The numerator represents the distance between the participant and the chart, and the denominator represents the distance at which a person with 'normal' vision would be able to discern the same letter size. 20/20 is considered to be 'normal' vision, whereas visual acuity of 20/40 means the participant is able to read a certain size letter 20 feet away that a person with 'normal' vision would be able to read from 40 feet away. A larger denominator, therefore, indicates a lower visual acuity.</description>
          <population>This analysis population includes all randomized and dispensed participants who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="50"/>
                <count group_id="O3" value="50"/>
                <count group_id="O4" value="50"/>
                <count group_id="O5" value="26"/>
                <count group_id="O6" value="26"/>
                <count group_id="O7" value="26"/>
                <count group_id="O8" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>20/15</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>20/20</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40"/>
                    <measurement group_id="O2" value="38"/>
                    <measurement group_id="O3" value="40"/>
                    <measurement group_id="O4" value="42"/>
                    <measurement group_id="O5" value="22"/>
                    <measurement group_id="O6" value="24"/>
                    <measurement group_id="O7" value="21"/>
                    <measurement group_id="O8" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>20/25</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="6"/>
                    <measurement group_id="O5" value="4"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="4"/>
                    <measurement group_id="O8" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>20/30</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Binocular Snellen Visual Acuity (VA) at Near (40cm) With Study Lenses</title>
        <description>Visual Acuity was tested while reading charts at a distance of 40 cm from the participant with both eyes together. The Snellen fraction 20/20 represents 'normal' near vision. A larger denominator indicates a lower visual acuity.</description>
        <time_frame>Up to Day 30</time_frame>
        <population>This reporting group includes all randomized and dispensed participants who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>DACP MF @ Dispense</title>
            <description>Nelfilcon A multifocal contact lens with comfort additive worn for 30 days on a daily wear, daily disposable basis</description>
          </group>
          <group group_id="O2">
            <title>DACP MF @ Day 3</title>
            <description>Nelfilcon A multifocal contact lens with comfort additive worn for 30 days on a daily wear, daily disposable basis</description>
          </group>
          <group group_id="O3">
            <title>DACP MF @ Day 14</title>
            <description>Nelfilcon A multifocal contact lens with comfort additive worn for 30 days on a daily wear, daily disposable basis</description>
          </group>
          <group group_id="O4">
            <title>DACP MF @ Day 30</title>
            <description>Nelfilcon A multifocal contact lens with comfort additive worn for 30 days on a daily wear, daily disposable basis</description>
          </group>
          <group group_id="O5">
            <title>FDP @ Dispense</title>
            <description>Nelfilcon A multifocal contact lens worn for 30 days on a daily wear, daily disposable basis</description>
          </group>
          <group group_id="O6">
            <title>FDP @ Day 3</title>
            <description>Nelfilcon A multifocal contact lens worn for 30 days on a daily wear, daily disposable basis</description>
          </group>
          <group group_id="O7">
            <title>FDP @ Day 14</title>
            <description>Nelfilcon A multifocal contact lens worn for 30 days on a daily wear, daily disposable basis</description>
          </group>
          <group group_id="O8">
            <title>FDP @ Day 30</title>
            <description>Nelfilcon A multifocal contact lens worn for 30 days on a daily wear, daily disposable basis</description>
          </group>
        </group_list>
        <measure>
          <title>Binocular Snellen Visual Acuity (VA) at Near (40cm) With Study Lenses</title>
          <description>Visual Acuity was tested while reading charts at a distance of 40 cm from the participant with both eyes together. The Snellen fraction 20/20 represents 'normal' near vision. A larger denominator indicates a lower visual acuity.</description>
          <population>This reporting group includes all randomized and dispensed participants who completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="50"/>
                <count group_id="O3" value="50"/>
                <count group_id="O4" value="50"/>
                <count group_id="O5" value="26"/>
                <count group_id="O6" value="26"/>
                <count group_id="O7" value="26"/>
                <count group_id="O8" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>20/10</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>20/12.5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="2"/>
                    <measurement group_id="O8" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>20/16</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="2"/>
                    <measurement group_id="O8" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>20/20</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                    <measurement group_id="O2" value="18"/>
                    <measurement group_id="O3" value="15"/>
                    <measurement group_id="O4" value="23"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="5"/>
                    <measurement group_id="O7" value="5"/>
                    <measurement group_id="O8" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>20/25</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                    <measurement group_id="O2" value="24"/>
                    <measurement group_id="O3" value="25"/>
                    <measurement group_id="O4" value="20"/>
                    <measurement group_id="O5" value="14"/>
                    <measurement group_id="O6" value="10"/>
                    <measurement group_id="O7" value="10"/>
                    <measurement group_id="O8" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>20/30</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>20/32</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="7"/>
                    <measurement group_id="O5" value="7"/>
                    <measurement group_id="O6" value="8"/>
                    <measurement group_id="O7" value="5"/>
                    <measurement group_id="O8" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>20/40</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="1"/>
                    <measurement group_id="O8" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>20/50</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>An AE was defined as any untoward medical occurrence, unintended disease or injury, or untoward clinical sign in subjects, users, or other persons, whether or not related to the medical device. AEs were collected for the duration of the study (2 months).</time_frame>
      <desc>AEs were obtained as solicited comments and as observations by the study Investigator as outlined in the study protocol. This analysis population includes all randomized participants who were dispensed study product (79).</desc>
      <group_list>
        <group group_id="E1">
          <title>DAILIES® AquaComfort Plus® Multifocal</title>
          <description>Nelfilcon A multifocal contact lens with comfort additive worn for 30 days on a daily wear, daily disposable basis</description>
        </group>
        <group group_id="E2">
          <title>Focus® DAILIES® Progressives</title>
          <description>Nelfilcon A multifocal contact lens worn for 30 days on a daily wear, daily disposable basis</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="27"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="27"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Sponsor reserves the right of prior review of any publication or presentation of information related to the study.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Stacie Cummings, O.D.</name_or_title>
      <organization>Alcon Research, Ltd.</organization>
      <phone>1-888-451-3937</phone>
      <email>alcon.medinfo@alcon.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

